Subscriber ContentRead Preview
Timothy M. Armstrong bought stock as it hovers near a 52-week low.
Subscriber ContentRead Preview
Goldman Sachs tells clients to prepare for the retail stock to make a big move in response to the next earnings report.
Subscriber Content Read Preview
A strong outlook for 2011 suggests that the beverage company's stock should rise further.
Subscriber Content Read Preview
Weight Watchers and Williams rose. NetApp and Liz Claiborne fell.
Subscriber Content Read Preview
China Telecom is taking preorders but China Mobile has other ideas.
Subscriber Content Read Preview
The "smart grid" firm likely isn't seeing a North American rebound.
Subscriber Content Read Preview
Credit Suisse expects Kellogg to gain share from Quaker Oats and Post.
Subscriber Content Read Preview
The insurer may see brokerage and consulting margins rise.
Subscriber Content Read Preview
Markets show QE2 counts more than interest rates. Question for second half of 2010.
Subscriber Content Read Preview
Japanese currency shows signs of significant weakening ahead as economy falls to No. 3 and as its debt burgeons.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
The tech titan tops our global ranking for the second straight year, followed by Amazon and Berkshire Hathaway.
Editor and President Ed Finn explains how you can use Barron's to become a better investor. Watch video
UNG | BCSI | CLWR | MORN | GLD |
DPS | INTC | ADP | GS | MRVL |
CBS | BLK | APEI | SLV | ESLR |
BAL | KFT | JWN | FMCC | BRCM |
Subscriber Content Read Preview
Slowing growth abroad will likely be a drag for the U.S.
The chief investment officer of Rosenau/Paul thinks the time is finally here for large-cap stocks with growing dividends. Here's what she's been buying.
Regardless of what path Egypt now follows, a leading analyst says the price of oil is headed toward $300 a barrel based on basic supply-and-demand forces.
With drug stocks ailing, companies like Abbott and Medtronic should start shedding non-core businesses. For investors, it would be just the right medicine.
Business ethicists and advocates for corporate social responsibility are playing a dangerous game.
This feature tracks the performance of stocks Barron's has written about during 2011 -- both favorably and critically. For stocks featured in Barron's print magazine, prices are measured from the Friday before publication date to their current price. For stocks featured on Barrons.com, prices are measured from the trading day of publication date to their current price. This list includes U.S. stocks only, including ADRs, but not foreign stocks.